MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
MiR-34a acts as a candidate tumour suppressor gene, and its expression is reduced in several cancer types. We aimed to study miR-34a expression in breast cancer and its correlation with tumour characteristics and clinical outcome, and regulatory links with other genes. We analysed miR-34a expression...
Main Authors: | Peurala, Hanna, Greco, Dario, Heikkinen, Tuomas, Kaur, Sippy, Bartkova, Jirina, Jamshidi, Maral, Aittomäki, Kristiina, Heikkilä, Päivi, Bartek, Jiri, Blomqvist, Carl, Bützow, Ralf, Nevanlinna, Heli |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213093/ |
Similar Items
-
Variants on the promoter region of PTEN affect breast cancer progression and patient survival
by: Heikkinen, Tuomas, et al.
Published: (2011) -
Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
by: Eerola, Hannaleena, et al.
Published: (2005) -
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
by: Eerola, Hannaleena, et al.
Published: (2005) -
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
by: Kiiski, Johanna I., et al.
Published: (2016) -
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
by: Muranen, Taru A, et al.
Published: (2011)